<DOC>
	<DOCNO>NCT01797978</DOCNO>
	<brief_summary>This study see whether intravenous administration methylene blue improve outcome severe sepsis septic shock .</brief_summary>
	<brief_title>Methylene Blue Severe Sepsis Septic Shock</brief_title>
	<detailed_description>The mortality septic shock still high range 30 50 % . Vasopressor main part manage septic shock , choice vasopressor still under-investigated , area uncertainty . The response vasopressor sometimes unsatisfactory , case , outcome patient poor . Recently , small size clinical trial investigate effect methylene blue ( MB ) , show promising result . However , large size phase III trial perform yet . Large sized phase III clinical trial need establish effect MB septic shock .</detailed_description>
	<mesh_term>Shock</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Methylene Blue</mesh_term>
	<criteria>Septic shock meeting criterion 2012 survive sepsis campaign Need norepinephrine 0.2microgram/kg/min Pregnancy Less 18 year old Terminal cancer patient Declined consent glucose6phosphate dehydrogenase deficiency Medication Serotonin modulator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Septic shock</keyword>
	<keyword>Methylene blue</keyword>
</DOC>